top of page
Testing for RET
A free webinar series for endocrinologists and other healthcare professionals
Not an approved CE Course
Welcome to our webinar series on RET-driven cancers. The RET gene plays a crucial role in the development and function of the nervous system and endocrine system, and mutations in this gene can increase the risk of developing cancer. In this webinar series, we will delve into the relationship between RET gene alterations and cancer, focusing on the types of cancer that are most commonly associated with these alterations, such as medullary thyroid cancer and multiple endocrine neoplasia type 2. We will also discuss the latest research on the testing and treatment of RET gene mutation-associated cancer, including emerging therapies such as NTRK inhibitors. Whether you are a healthcare professional, a patient, or simply interested in learning more about this important topic, we hope that you will find this series informative and engaging. Let's get started!
Testing for RET is provided by Lighthouse, a Celerity Biosciences Subsidairy, and Funded by Loxo Oncology at Lilly
bottom of page